NOS3 and cardiovascular disorder: A reduction in protective substances within the endothelium—such as endothelial nitric oxide synthase (eNOS)—known as endothelial dysfunction, along with high levels of ROS, a key factor leading to this dysfunction, results in an elevated incidence of cardiovascular disease (CVD) [40,41].